Business Description
Greenland Mines Ltd
NAICS : 212220
SIC : 1041
ISIN : US49876K1034
Description
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 33.91 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.64 | |||||
9-Day RSI | 45.06 | |||||
14-Day RSI | 42.05 | |||||
3-1 Month Momentum % | -26.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 19.73 | |||||
Quick Ratio | 19.73 | |||||
Cash Ratio | 18.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -26.92 | |||||
ROA % | -23.2 | |||||
ROIC % | -19.23 | |||||
ROC (Joel Greenblatt) % | -28.23 | |||||
ROCE % | -23.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.57 | |||||
Price-to-Tangible-Book | 0.59 | |||||
EV-to-EBIT | -1.96 | |||||
EV-to-EBITDA | -1.96 | |||||
EV-to-FCF | -5.09 | |||||
| Price-to-Net-Current-Asset-Value | 12.41 | |||||
| Price-to-Net-Cash | 24.82 | |||||
Earnings Yield (Greenblatt) % | -51.02 | |||||
FCF Yield % | -14.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GRML
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Greenland Mines Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.15 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 42.05 | ||
| 14-Day ATR ($) | 0.033711 | ||
| 20-Day SMA ($) | 0.263218 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.2052 - 0.5496 | ||
| Shares Outstanding (Mil) | 150.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Greenland Mines Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Greenland Mines Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Greenland Mines Ltd Frequently Asked Questions
What is Greenland Mines Ltd(GRML)'s stock price today?
The current price of GRML is $0.25. The 52 week high of GRML is $0.55 and 52 week low is $0.21.
When is next earnings date of Greenland Mines Ltd(GRML)?
The next earnings date of Greenland Mines Ltd(GRML) is .
Does Greenland Mines Ltd(GRML) pay dividends? If so, how much?
Greenland Mines Ltd(GRML) does not pay dividend.
Guru Commentaries on NAS:GRML
No articles.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers